NNNN
Anbio Biotechnology Class A Ordinary Shares
NASDAQ: NNNN · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$27.43
-1.37% today
Updated 2026-04-29
Market cap
$1.20B
P/E ratio
182.87
P/S ratio
139.23x
EPS (TTM)
$0.15
Dividend yield
—
52W range
$6 – $56
Volume
0.0M
Anbio Biotechnology Class A Ordinary Shares (NNNN) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$27.43
12-Month target
$0.68
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 74.10%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.